MRI radiomics model for predicting TERT promoter mutation status in glioblastoma

被引:4
|
作者
Chen, Ling [1 ,2 ]
Chen, Runrong [1 ]
Li, Tao [2 ]
Huang, Lizhao [2 ]
Tang, Chuyun [1 ]
Li, Yao [3 ]
Zeng, Zisan [1 ]
机构
[1] Guangxi Med Univ, Affiliated Hosp 1, Dept Radiol, Nanning, Guangxi, Peoples R China
[2] Guangxi Med Univ, Liuzhou Workers Hosp, Affiliated Hosp 4, Dept Radiol, Nanning, Guangxi, Peoples R China
[3] Guangxi Med Univ, Liuzhou Workers Hosp, Affiliated Hosp 4, Dept Neurosurg, Nanning, Guangxi, Peoples R China
来源
BRAIN AND BEHAVIOR | 2023年 / 13卷 / 12期
关键词
glioblastoma; magnetic resonance imaging; radiomics; TERT; IDH MUTATION; METHYLATION; FEATURES; GLIOMAS;
D O I
10.1002/brb3.3324
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Background and purposeThe presence of TERT promoter mutations has been associated with worse prognosis and resistance to therapy for patients with glioblastoma (GBM). This study aimed to determine whether the combination model of different feature selections and classification algorithms based on multiparameter MRI can be used to predict TERT subtype in GBM patients.MethodsA total of 143 patients were included in our retrospective study, and 2553 features were obtained. The datasets were randomly divided into training and test sets in a ratio of 7:3. The synthetic minority oversampling technique was used to achieve data balance. The Pearson correlation coefficients were used for dimension reduction. Three feature selections and five classification algorithms were used to model the selected features. Finally, 10-fold cross validation was applied to the training dataset.ResultsA model with eight features generated by recursive feature elimination (RFE) and linear discriminant analysis (LDA) showed the greatest diagnostic performance (area under the curve values for the training, validation, and testing sets: 0.983, 0.964, and 0.926, respectively), followed by relief and random forest (RF), analysis of variance and RF. Furthermore, the relief was the optimal feature selection for separately evaluating those five classification algorithms, and RF was the most preferable algorithm for separately assessing the three feature selectors. ADC entropy was the parameter that made the greatest contribution to the discrimination of TERT mutations.ConclusionsRadiomics model generated by RFE and LDA mainly based on ADC entropy showed good performance in predicting TERT promoter mutations in GBM. Adult glioblastoma (GBM) is the most common and aggressive primary brain tumor, with a high recurrence and mortality rate. The presence of TERT promoter mutations has been associated with poor prognosis and resistance to therapy, making it an important biomarker for personalized treatment strategies. In this study, we investigated the relationship between multiparameter MRI features and TERT mutation status, establishing a radiomics signature for predicting TERT promoter mutation status, and verified its effectiveness in prognostic assessment with GBM patients. image
引用
收藏
页数:11
相关论文
共 50 条
  • [31] A MRI-BASED RADIOMICS MODEL PREDICTING DNA DAMAGE REPAIR GENES EXPRESSION SUBTYPES AND PROGNOSIS IN GLIOBLASTOMA
    Zhang, Mingwei
    Wu, Yufan
    Li, Xiaoxia
    Wang, Xuezhen
    Li, Shan
    Hong, Jinsheng
    NEURO-ONCOLOGY, 2023, 25
  • [32] TERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma
    Griewank, Klaus G.
    Murali, Rajmohan
    Puig-Butille, Joan Anton
    Schilling, Bastian
    Livingstone, Elisabeth
    Potrony, Miriam
    Carrera, Cristina
    Schimming, Tobias
    Moeller, Inga
    Schwamborn, Marion
    Sucker, Antje
    Hillen, Uwe
    Badenas, Celia
    Malvehy, Josep
    Zimmer, Lisa
    Scherag, Andre
    Puig, Susana
    Schadendorf, Dirk
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (09):
  • [33] TERT promoter mutation status is an independent prognostic factor in cutaneous melanoma
    Griewank, K.
    Murali, R.
    Puig-Butille, J.
    Schilling, B.
    Livingstone, E.
    Potrony, M.
    Carrera, C.
    Schimming, T.
    Moeller, I.
    Schwamborn, M.
    Sucker, A.
    Hillen, U.
    Badenas, C.
    Malvehy, J.
    Zimmer, L.
    Scherag, A.
    Puig, S.
    Schadendorf, D.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2014, 12 : 5 - 5
  • [34] Contribution of TERT promoter mutation status to preoperative diagnosis of thyroid carcinoma
    Bella-Cueto, M.
    Carrera, R.
    Ramos, M. D. C.
    Rodriguez, M.
    Vazquez, J. A.
    Onieva, R.
    Capel, I.
    Blazquez, C. M.
    Andreu, F. J.
    Escoda, M.
    Prenafeta, M.
    Barcons, S.
    Perez, V.
    Cano-Palomares, A.
    Guirao, F. X.
    Nebot, L.
    Gallardo, E.
    Rigla, M.
    Combalia, N.
    VIRCHOWS ARCHIV, 2019, 475 : S14 - S14
  • [35] Impact of experimental design on PET radiomics in predicting somatic mutation status
    Yip, Stephen S. F.
    Parmar, Chintan
    Kim, John
    Huynh, Elizabeth
    Mak, Raymond H.
    Aerts, Hugo J. W. L.
    EUROPEAN JOURNAL OF RADIOLOGY, 2017, 97 : 8 - 15
  • [36] MULTIREGIONAL RADIOMICS PROFILING FROM MULTIPARAMETRIC MRI: IDENTIFYING AN IMAGING PREDICTOR OF IDH1 MUTATION STATUS IN GLIOBLASTOMA MULTIFORME
    Chen, Yin-sheng
    Chen, Zhong-ping
    Li, Zhicheng
    Bai, Hongmin
    Liang, Chaofeng
    NEURO-ONCOLOGY, 2018, 20 : 178 - 178
  • [37] TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma
    Kenji Fujimoto
    Hideyuki Arita
    Kaishi Satomi
    Kai Yamasaki
    Yuko Matsushita
    Taishi Nakamura
    Yasuji Miyakita
    Toru Umehara
    Keiichi Kobayashi
    Kaoru Tamura
    Shota Tanaka
    Fumi Higuchi
    Yoshiko Okita
    Yonehiro Kanemura
    Junya Fukai
    Daisuke Sakamoto
    Takehiro Uda
    Ryunosuke Machida
    Aya Kuchiba
    Taketoshi Maehara
    Motoo Nagane
    Ryo Nishikawa
    Hiroyoshi Suzuki
    Makoto Shibuya
    Takashi Komori
    Yoshitaka Narita
    Koichi Ichimura
    Acta Neuropathologica, 2021, 142 : 323 - 338
  • [38] TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma
    Fujimoto, Kenji
    Arita, Hideyuki
    Satomi, Kaishi
    Yamasaki, Kai
    Matsushita, Yuko
    Nakamura, Taishi
    Miyakita, Yasuji
    Umehara, Toru
    Kobayashi, Keiichi
    Tamura, Kaoru
    Tanaka, Shota
    Higuchi, Fumi
    Okita, Yoshiko
    Kanemura, Yonehiro
    Fukai, Junya
    Sakamoto, Daisuke
    Uda, Takehiro
    Machida, Ryunosuke
    Kuchiba, Aya
    Maehara, Taketoshi
    Nagane, Motoo
    Nishikawa, Ryo
    Suzuki, Hiroyoshi
    Shibuya, Makoto
    Komori, Takashi
    Narita, Yoshitaka
    Ichimura, Koichi
    ACTA NEUROPATHOLOGICA, 2021, 142 (02) : 323 - 338
  • [39] MULTIREGIONAL RADIOMICS PROFILING FROM MULTIPARAMETRIC MRI: IDENTIFYING AN IMAGING PREDICTOR OF IDH1 MUTATION STATUS IN GLIOBLASTOMA MULTIFORME
    Chen, Y.
    Chen, Z.
    Li, Z.
    Bai, H.
    Liang, C.
    NEURO-ONCOLOGY, 2018, 20 : 291 - 291
  • [40] Predicting Glioblastoma Cell Motility with Radiomics
    Mulford, K.
    McMahon, M.
    Odde, D.
    Wilke, C.
    MEDICAL PHYSICS, 2020, 47 (06) : E433 - E434